In the recent article by Tsunekawa et al, 1 3 days of therapy with the HMG Co-A reductase inhibitor cerivastatin improved flow-mediated vasodilation (FMD) of the brachial artery in a cohort of 27 older patients with diabetes mellitus (mean age 69.3Ϯ3.4 years). We found the results of this investigation puzzling for two reasons.
Response
We are grateful to Drs Stein and Carlson for their interest in our article. 1 We were also surprised by the drastic change of flow mediated vasodilatation (FMD) after statin therapy. However, the adequacy of the results was supported by the increase of both plasma NO 2 Ϫ /NO 3 Ϫ and cGMP concentration. Moreover, a decrease of plasma 8 isoprostane, an oxidant marker, may increase NO bioavailability. We cannot discuss the reason of the discrepancy between our data and theirs, because their report has not yet been published. However, the hypercholesterolemia in their subjects is itself known to impair FMD. Our previous data regarding a rabbit model showed that impaired endotheliumdependent relaxation in hypercholesterolemia-induced atherosclerosis could not be restored easily. 2 For that reason, we selected subjects without severe hypercholesterolemia (total cholesterol 200 to 260 mg/dL). The impairment of endotheliumdependent relaxation in diabetes mellitus is suggested not to be severe, and scavenging oxygen radicals could restore it. Moreover, the difference in non-lipid-mediated effects between statins should be considered, because cerivastatin has the strongest bioavailability among statins currently accessible. Recently, cerivastatin was reported to have a stronger pleiotropic effect than atrovastatin. 3 Their second question is in regard to the fact that FMD exceeded nitroglycerin-induced endothelium independent dilatation (NTG-D) after statin therapy. We suggest the lack of validity of comparing FMD and NTG-D using this method. Because the conditions of the two measurements are completely different (ie, reactive hyperemia and sublingual perfusion of nitroglycerin), and both values were decided at only one point (5 minutes prevention of blood flow in measuring FMD and 300 g nitroglycerin infusion in measuring NTG-D). In comparing the endothelium-dependent ability of smooth muscle cell relaxation with that of the endothelium-independent ability, the same mode of drug administration or stimulus to induce vascular response should be applied. It may be useful to examine the cumulative concentration of acetylcholine and nitroglycerin infusion into the brachial artery. 4 Moreover, we should be aware of each patient's profile, because NTG-D is reduced in elderly diabetic subjects. Both endothelium-dependent and endothelium-independent relaxations are impaired in diabetic patients. 5 In our previous study, diabetes and aging synergistically impaired endotheliumindependent relaxation. The possible effect of aging in drug absorption by sublingual infusion of NTG also has to be considered. Certainly, a non-invasive technique using sonography is insightful; however, we are aware of the limitations of this methodology for interpreting the results. Although we applaud their interest in geriatrics, we must comment that the question raised is neither essential nor relevant because of the reasons described above.
